Shauna Whisenton was once an individual living with sickle cell disease (SCD).
Her doctor asked her to consider a bone marrow transplant clinical trial to cure SCD.
Within nine months of receiving the bone marrow transplant, Whisenton received the news that she was SCD free and now only carries the trait.
She’s the manager of sickle cell disease community engagement for the ASH Research Collaborative (ASH RC) Sickle Cell Disease Clinical Trials Network (CTN), established by the American Society of Hematology, the world’s largest professional society concerned with the causes and treatments of blood disorders.
Whisenton is carrying out the mission of the ASH RC CTN to improve the lives of individuals with SCD by expediting the development of new therapies through innovative clinical trial research.
